CLINICAL TRIALS PROFILE FOR BENZONATATE
✉ Email this page to a colleague
All Clinical Trials for benzonatate
| Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
|---|---|---|---|---|---|---|
| NCT01690975 ↗ | Benzonatate Dose Tolerance Study | Completed | Pfizer | Phase 1 | 2012-07-01 | This is a single-center, randomized, third party blind, placebo controlled, dose escalation study of benzonatate following single dose administration. The primary oobjective is to assess the safety and tolerability of increasing oral doses of benzonatate following single dose administration in healthy male and female subjects. |
| NCT02207699 ↗ | Evaluation of the Effect of Benzonatate on QT Intervals Following Single Dose Administration of Benzonatate to Healthy Volunteers | Completed | Pfizer | Phase 1 | 2014-05-01 | The primary objective of this study is to determine the effects of benzonatate (200 mg and 800 mg) on the QT interval following single dose oral administration at each time point post-dose. |
| NCT03722914 ↗ | A Study on the Efficacy and Safety of Benzonatate Soft Capsules for Improving Adult Cough Symptoms | Unknown status | CSPC ZhongQi Pharmaceutical Technology Co., Ltd. | Phase 3 | 2018-03-01 | The purpose of this study is evaluate the efficay and safety of benzonatate soft capsules for improving adult cough symtoms. |
| >Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for benzonatate
Condition Name
Clinical Trial Locations for benzonatate
Trials by Country
Clinical Trial Progress for benzonatate
Clinical Trial Phase
Clinical Trial Sponsors for benzonatate
Sponsor Name
